Protocol No
SURG-HANSA-CONFIDES
Phase
III
Summary
This project is being done to demonstrate the efficacy and safety of Imlifidase, a new medication, in the management of highly sensitized kidney transplant patients.
Description
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx (ConfIdeS)
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov